Sharon Osbourne In early 2026, KFF reported that up to 60% of older adults taking GLP-1s may stop using them within a year
Always, without exception, verify the concentration on your vial before looking at any dosing chart
As with other retatrutide trials, weight loss and HbA1c improvement were lower than in the non-diabetic TRIUMPH-1 population (28.3%) a pattern consistent across the GLP-1 drug class, where type 2 diabetes reduces the magnitude of weight loss achieved
On GLP-Squared at $289/mo, the math matches the injection protocol
You're not alone if youre struggling to lose weight even with a healthy diet and exercise
Combined antioxidant, anti-inflammaging and mesenchymal stem cell treatment: a possible therapeutic direction in elderly patients with chronic obstructive pulmonary disease